Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations

Reproductive Toxicology

Volumn 23, Issue 3, 2007, Pages 366-373

  Ge, Ren Shan ^a   Chen, Guo Rong ^b   Tanrikut, Cigdem ^a,c   Hardy, Matthew P ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anti androgens; Phthalate Esters; Puberty; Steroidogenesis; Testosterone

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIBUTYL ESTER; PHTHALIC ACID ESTER; SOMATOMEDIN BINDING PROTEIN 3; TESTOSTERONE;

ARTICLE; BIRTH; CELL HYPERPLASIA; CELL VOLUME; CRYPTORCHISM; DEVELOPMENTAL BIOLOGY; DOSE CALCULATION; ECTOPIC TESTIS; FETUS CELL; HUMAN; HYPOSPADIAS; HYPOTHESIS; INSULIN SYNTHESIS; LEYDIG CELL; MALE INFERTILITY; NEOPLASM; NONHUMAN; PERINATAL DEVELOPMENT; PRENATAL EXPOSURE; SENSITIVITY ANALYSIS; SPERMATOGENESIS; STEROIDOGENESIS; TESTIS; TESTIS ATROPHY;

ANIMALS; DIETHYLHEXYL PHTHALATE; FEMALE; GONADAL DYSGENESIS; LEYDIG CELLS; MALE; MATERNAL EXPOSURE; MOLECULAR STRUCTURE; PLASTICIZERS; PREGNANCY;

RODENTIA;

EID: 34247143380     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.12.006     Document Type: Article

References (83)

1. Sharpe R.M. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett 120 (2001) 221-232
2. Akingbemi B.T., Youker R.T., Sottas C.M., Ge R., Katz E., Klinefelter G.R., et al. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol Reprod 65 (2001) 1252-1259
3. Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., Guillette Jr. L.J., et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104 (1996) 741-803
4. Boisen K.A., Kaleva M., Main K.M., Virtanen H.E., Haavisto A.M., Schmidt I.M., et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363 (2004) 1264-1269
5. Skakkebaek N.E., Rajpert-De Meyts E., and Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16 (2001) 972-978
6. Blount B.C., Silva M.J., Caudill S.P., Needham L.L., Pirkle J.L., Sampson E.J., et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 108 (2000) 979-982
7. NTP-CERHR Expert Panel Report on Di(2-ethylhexyl) Phthalate. Alexandria, VA: Science International, Inc.; 2000.
8. ATSDR. Toxicological profile for di(2-ethylhexyl) phthalate (1993), Agency for Toxic Substances and Disease Registry, Atlanta, GA
9. Silva M.J., Barr D.B., Reidy J.A., Malek N.A., Hodge C.C., Caudill S.P., et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 112 (2004) 331-338
10. Koo J.W., Parham F., Kohn M.C., Masten S.A., Brock J.W., Needham L.L., et al. The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population. Environ Health Perspect 110 (2002) 405-410
11. Main K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 114 (2006) 270-276
12. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113 (2005) 1056-1061
13. Aldyreva M.V., Klimova T.S., Iziumova A.S., and Timofeevskaia L.A. The effect of phthalate plasticizers on the generative function. Gig Tr Prof Zabol (1975) 25-29
14. Borch J., Axelstad M., Vinggaard A.M., and Dalgaard M. Diisobutyl phthalate has comparable anti-androgenic effects to di-n-butyl phthalate in fetal rat testis. Toxicol Lett 163 (2006) 183-190
15. Kim H.S., Kim T.S., Shin J.H., Moon H.J., Kang I.H., Kim I.Y., et al. Neonatal exposure to di(n-butyl) phthalate (DBP) alters male reproductive-tract development. J Toxicol Environ Health A 67 (2004) 2045-2060
16. FDA. Safety Assessment of Di-(2-ethylhexyl) Phthalate (DEHP) Released from PVC Medical Devices; 2001. http://www.fda.gov/cdrh/ost/dehp-pvc.pdf.
17. David R.M. Proposed mode of action for in utero effects of some phthalate esters on the developing male reproductive tract. Toxicol Pathol 34 (2006) 209-219
18. Huhtaniemi I., and Pelliniemi L.J. Fetal Leydig cells: cellular origin, morphology, life span, and special functional features. Proc Soc Exp Biol Med 201 (1992) 125-140
19. Habert R., and Brignaschi P. Developmental changes in in vitro testosterone production by dispersed Leydig cells during fetal life in rats. Arch Androl 27 (1991) 65-71
20. Scott D.J., Fu P., Shen P.J., Gundlach A., Layfield S., Riesewijk A., et al. Characterization of the rat INSL3 receptor. Ann N Y Acad Sci 1041 (2005) 13-16
21. Adham I.M., Emmen J.M., and Engel W. The role of the testicular factor INSL3 in establishing the gonadal position. 36. Mol Cell Endocrinol 160 (2000) 11-16
22. Adham I.M., and Agoulnik A.I. Insulin-like 3 signalling in testicular descent. Int J Androl 27 (2004) 257-265
23. Bay K., Hartung S., Ivell R., Schumacher M., Jurgensen D., Jorgensen N., et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 90 (2005) 3410-3418
24. Codesal J., Regadera J., Nistal M., Regadera-Sejas J., and Paniagua R. Involution of human fetal Leydig cells. An immunohistochemical, ultrastructural and quantitative study. J Anat 172 (1990) 103-114
25. Kerr J.B. A light microscopic and morphometric analysis of the Sertoli cell during the spermatogenic cycle of the rat. Anat Embryol (Berl) 177 (1988) 341-348
26. Zhang F.P., Pakarainen T., Zhu F., Poutanen M., and Huhtaniemi I. Molecular characterization of postnatal development of testicular steroidogenesis in luteinizing hormone receptor knockout mice. Endocrinology 145 (2004) 1453-1463
27. Zhang F.-P., Poutanen M., Wilbertz J., and Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LHRKO) mice. Mol Endocrinol 15 (2001) 172-183
28. Lei Z.M., Mishra S., Zou W., Xu B., Foltz M., Li X., et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 15 (2001) 184-200
29. Ariyaratne H.B., Mendis-Handagama S.M., Hales D.B., and Mason I.J. Studies of the onset of Leydig cell differentiation in the prepubertal rat testis. Biol Reprod 63 (2000) 165-171
30. Ge R.S., Shan L.X., and Hardy M.P. Pubertal development of Leydig cells. In: Payne A.H., Hardy M.P., and Russell L.D. (Eds). The Leydig cell. (1996), Cache River Press, Vienna, IL 159-173
31. Kaul A.F., Souney P.F., and Osathanondh R. A review of possible toxicity of di-2-ethylhexylphthalate (DEHP) in plastic intravenous containers: effects on reproduction. Drug Intell Clin Pharm 16 (1982) 689-692
32. Fisher J.S., Macpherson S., Marchetti N., and Sharpe R.M. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod 18 (2003) 1383-1394
33. Ema M., Miyawaki E., and Kawashima K. Further evaluation of developmental toxicity of di-n-butyl phthalate following administration during late pregnancy in rats. Toxicol Lett 98 (1998) 87-93
34. Ema M., Miyawaki E., and Kawashima K. Critical period for adverse effects on development of reproductive system in male offspring of rats given di-n-butyl phthalate during late pregnancy. Toxicol Lett 111 (2000) 271-278
35. Mylchreest E., Cattley R.C., and Foster P.M. Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: an antiandrogenic mechanism?. Toxicol Sci 43 (1998) 47-60
36. Mylchreest E., Wallace D.G., Cattley R.C., and Foster P.M. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl). Toxicol Sci 55 (2000) 143-151
37. Parks L.G., Ostby J.S., Lambright C.R., Abbott B.D., Klinefelter G.R., Barlow N.J., et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 58 (2000) 339-349
38. Stoker T.E., Parks L.G., Gray L.E., and Cooper R.L. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. 259. Crit Rev Toxicol 30 (2000) 197-252
39. Wilson V.S., Lambright C., Furr J., Ostby J., Wood C., Held G., et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rattestis. Toxicol Lett 146 (2004) 207-215
40. Ge R., Chen G., Sottas C.M., and Hardy P.H. Effects of prenatal exposures to phthalate on fetal Leydig cell numbers and distribution in the testis of the Long Evans rat. The Endocrine Society's 88th Annual Meeting. Boston, MA (2006) 1-171
41. Barlow N.J., McIntyre B.S., and Foster P.M. Male reproductive tract lesions at 6, 12, and 18 months of age following in utero exposure to di(n-butyl) phthalate. Toxicol Pathol 32 (2004) 79-90
42. Liu K., Lehmann K.P., Sar M., Young S.S., and Gaido K.W. Gene expression profiling following in utero exposure to phthalate esters reveals new gene targets in the etiology of testicular dysgenesis. Biol Reprod 73 (2005) 180-192
43. Barlow N.J., Phillips S.L., Wallace D.G., Sar M., Gaido K.W., and Foster P.M. Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicol Sci 73 (2003) 431-441
44. Leung P.S., and Sernia C. The renin-angiotensin system and male reproduction: new functions for old hormones. J Mol Endocrinol 30 (2003) 263-270
45. Dufau M.L., Ulisse S., Khanum A., Buczko E., Kitamura M., Fabbri A., et al. LH action in the Leydig cell: modulation by angiotensin II and corticotropin releasing hormone, and regulation of P450(17) alpha mRNA. J Steroid Biochem 34 (1989) 205-217 [Review] [59 refs.]
46. Tahri-Joutei A., Fillion C., Bedin M., Hugues J.N., and Pointis G. Local control of Leydig cell arginine vasopressin receptor by naloxone. Mol Cell Endocrinol 79 (1991) 21-24
47. Akingbemi B.T., and Hardy M.P. Oestrogenic and antiandrogenic chemicals in the environment: effects on male reproductive health. Ann Med 33 (2001) 391-403
48. Akingbemi B.T., Ge R., Klinefelter G.R., Zirkin B.R., and Hardy M.P. Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc Natl Acad Sci USA 101 (2004) 775-780
49. Kurahashi N., Kondo T., Omura M., Umemura T., Ma M., and Kishi R. The effects of subacute inhalation of di (2-ethylhexyl) phthalate (DEHP) on the testes of prepubertal Wistar rats. J Occup Health 47 (2005) 437-444
50. Castle W.N., and Richardson Jr. J.R. Leydig cell tumor and metachronous Leydig cell hyperplasia: a case associated with gynecomastia and elevated urinary estrogens. J Urol 136 (1986) 1307-1308
51. Navickis R.J., Shimkin M.B., and Hsueh A.J. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors. Cancer Res 41 (1981) 1646-1651
52. U.S. Dept. of Health and Human Services. Fourth Annual Report on Carcinogenesis. Washington, DC; 1985.
53. Sjoberg P., Bondesson U., Gray T.J., and Ploen L. Effects of di(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in vitro. Acta Pharmacol Toxicol (Copenh) 58 (1986) 225-233
54. Dostal L.A., Chapin R.E., Stefanski S.A., Harris M.W., and Schwetz B.A. Testicular toxicity and reduced Sertoli cell numbers in neonatal rats by di(2-ethylhexyl)phthalate and the recovery of fertility as adults. Toxicol Appl Pharmacol 95 (1988) 104-121
55. Grasso P., Heindel J.J., Powell C.J., and Reichert Jr. L.E. Effects of mono(2-ethylhexyl) phthalate, a testicular toxicant, on follicle-stimulating hormone binding to membranes from cultured rat Sertoli cells. Biol Reprod 48 (1993) 454-459
56. Gazouli M., Yao Z.X., Boujrad N., Corton J.C., Culty M., and Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143 (2002) 2571-2583
57. Ge R, Chen G, Sottas CM, Hardy MP. Low-dose postnatal exposures to diethylhexylphthalate (Dehp) promote precocity in male rats. Omaha, Nebraska; 2006.
58. David R.M. Exposure to phthalate esters. Environ Health Perspect 108 (2000) A440
59. Gray T.J., and Butterworth K.R. Testicular atrophy produced by phthalate esters. Arch Toxicol Suppl 4 (1980) 452-455
60. Kluwe W.M., McConnell E.E., Huff J.E., Haseman J.K., Douglas J.F., and Hartwell W.V. Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ Health Perspect 45 (1982) 129-133
61. Oishi S. Testicular atrophy induced by di(2-ethylhexyl)phthalate: changes in histology, cell specific enzyme activities and zinc concentrations in rat testis. Arch Toxicol 59 (1986) 290-295
62. Oishi S. Prevention of di(2-ethylhexyl)phthalate-induced testicular atrophy in rats by co-administration of the vitamin B12 derivative adenosylcobalamin. Arch Environ Contam Toxicol 26 (1994) 497-503
63. Sjoberg P., Lindqvist N.G., and Ploen L. Age-dependent response of the rat testes to di(2-ethylhexyl) phthalate. Environ Health Perspect 65 (1986) 237-242
64. Poon R., Lecavalier P., Mueller R., Valli V.E., Procter B.G., and Chu I. Subchronic oral toxicity of di-n-octyl phthalate and di(2-ethylhexyl) phthalate in the rat. Food Chem Toxicol 35 (1997) 225-239
65. Lamb J.C., Chapin R.E., Teague J., Lawton A.D., and Reel J.R. Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol 88 (1987) 255-269
66. Harris C.A., Henttu P., Parker M.G., and Sumpter J.P. The estrogenic activity of phthalate esters in vitro. Environ Health Perspect 105 (1997) 802-811
67. Gazouli M., Han Z., and Papadopoulos V. Identification of a peptide antagonist to the peripheral-type benzodiazepine receptor that inhibits hormone-stimulated leydig cell steroid formation. J Pharmacol Exp Ther 303 (2002) 627-632
68. Corton J.C., Anderson S.P., and Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40 (2000) 491-518
69. Lemberger T., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12 (1996) 335-363
70. Schultz R., Yan W., Toppari J., Volkl A., Gustafsson J.A., and Pelto-Huikko M. Expression of peroxisome proliferator-activated receptor alpha messenger ribonucleic acid and protein in human and rat testis. Endocrinology 140 (1999) 2968-2975
71. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
72. Hase T., Yoshimura R., Mitsuhashi M., Segawa Y., Kawahito Y., Wada S., et al. Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology 60 (2002) 542-547
73. Nemali M.R., Usuda N., Reddy M.K., Oyasu K., Hashimoto T., Osumi T., et al. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 48 (1988) 5316-5324
74. Hurst C.H., and Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 74 (2003) 297-308
75. Lampen A., Zimnik S., and Nau H. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol Appl Pharmacol 188 (2003) 14-23
76. Corton J.C., and Lapinskas P.J. Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?. Toxicol Sci 83 (2005) 4-17
77. Lapinskas P.J., Brown S., Leesnitzer L.M., Blanchard S., Swanson C., Cattley R.C., et al. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Toxicology 207 (2005) 149-163
78. Maloney E.K., and Waxman D.J. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161 (1999) 209-218
79. Papadopoulos V. In search of the function of the peripheral-type benzodiazepine receptor. Endocr Res 30 (2004) 677-684
80. O'Brien M.L., Spear B.T., and Glauert H.P. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit Rev Toxicol 35 (2005) 61-88
81. Mahood I.K., McKinnell C., Walker M., Hallmark N., Scott H., Fisher J.S., et al. Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate. Int J Androl 29 (2006) 148-154
82. Zacharewski T. Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays. Environ Health Perspect 106 Suppl 2 (1998) 577-582
83. Sharpe R.M., and Irvine D.S. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health?. BMJ 328 (2004) 447-451